1 The eects of isoenzyme-selective inhibitors of phosphodiesterases PDE3 and PDE4 on cyclic AMP concentration, two indices of phosphoinositide hydrolysis, and contractile responses to spasmogens have been investigated in bovine tracheal smooth muscle (BTSM). accumulation stimulated by muscarinic acetylcholine (mACh) receptor activation were less marked. However, combined PDE3/4 inhibition signi®cantly decreased this response at a submaximal concentration of mACh receptor agonist (carbachol; 1 mM). 4 The greater-than-additive eect of combined PDE3/4 inhibition was also observed at the level of contractile responses to histamine and carbachol. In experiments designed to investigate the eects of PDE3 and/or 4 inhibitors on the carbachol-mediated phasic contraction, additions of rolipram (10 mM) or ORG 9935 (1 mM) were without eect, whereas added together the inhibitors caused a signi®cant (P50.01) 40% reduction in the peak phasic contractile response. 5 The eect on contraction correlated with a substantial inhibitory eect of PDE3/4 inhibition on the initial increase in inositol 1,4,5-trisphosphate (InsP 3 ) accumulation stimulated by spasmogen. Thus, in the presence of ORG 9935 (1 mM) rolipram concentration-dependently inhibited carbachol-stimulated InsP 3 accumulation by 550% (7log EC 50 (M), 6.77+0.21; n=4). 6 Carbachol (100 mM) addition caused a rapid decrease (by 67% at 10 s) in BTSM cyclic AMP level in the presence of PDE3/4 inhibition. However, omission of Ca 2+ from the incubation medium prevented the carbachol-evoked decrease in cyclic AMP and this coincided with a greater inhibition (580%) of the carbachol-stimulated InsP 3 response. 7 These data indicate that combined PDE3 and PDE4 inhibition has greater-than-additive eects on second messenger and functional responses to spasmogens in BTSM. Furthermore, the ability of PDE3/4 inhibition signi®cantly to attenuate mACh receptor-mediated contractile responses, may be, at least in part, attributed to an eect exerted at the level of InsP 3 generation.
Introduction
The generation of the second messengers inositol 1,4,5-trisphosphate (InsP 3 ) and sn-1,2-diacylglycerol (DAG) plays a central role in the initiation and maintenance phases of airways smooth muscle contraction in response to stimulation of cellsurface G protein-coupled receptors (Takuwa et al., 1986; Miller-Hance et al., 1988; Roel et al., 1990; Chilvers et al., 1991; Schramm & Grunstein, 1992) . For example, activation of receptors for acetylcholine (M 3 -mACh receptors) and histamine (H 1 -receptors) results in a G protein-dependent activation of phosphoinositide-speci®c phospholipase C (PLC) to generate InsP 3 and DAG, which mobilize sarcoplasmic reticular Ca 2+ -stores (Hashimoto et al., 1985; Chilvers et al., 1990; Hoiting et al., 1996) , and activate protein kinase C (Langlands & Diamond, 1992; Yang & Black, 1995) , respectively.
Contraction of airways smooth muscle can be prevented (anti-spasmogenic eect) or reversed (spasmolytic eect) by agents which increase adenosine 3':5'-cyclic monophosphate (cyclic AMP) levels within the tissue (Scheid et al., 1979; Giembycz & Raeburn, 1991) , such as b-adrenoceptor agonists (Torphy, 1994; Kotliko & Kamm, 1996) and cyclic nucleotide phosphodiesterase (PDE) inhibitors Beavo, 1995) . A number of mechanisms have been proposed to account for the relaxant eect of cyclic AMP (see Giembycz & Raeburn, 1991; Kotliko & Kamm, 1996) , although which of these is physiologically most signi®cant remains unresolved (Rasmussen et al., 1990; Torphy, 1994) . One potentially important mechanism involves the ability of cyclic AMPelevating agents to inhibit receptor-mediated phosphoinositide turnover (Hall et al., 1989a; Madison & Brown, 1988) . This action seems to be spasmogen-dependent as, like the modulation of contractile responses (Torphy et al., 1985) , mACh receptor-stimulated phosphoinositide responses are relatively resistant to cyclic AMP-elevation compared to those elicited by other spasmogens (Hall et al., 1989a; Madison & Brown, 1988; Oer et al., 1991) .
Biochemical studies have demonstrated the presence of multiple PDE isoenzymes in airways smooth muscle, and isoenzyme-selective inhibitors have been used to de®ne which PDEs may play a physiologically important role, in dierent species including man, in regulating tissue cyclic AMP concentration (Torphy & Cieslinski, 1990; Giembycz & Barnes, 1991; Shahid et al., 1991; de Boer et al., 1992; Rabe et al., 1993; Torphy et al., 1993) . In the present study we have investigated the eect of inhibition of the low K m , cyclic AMPspeci®c (PDE4) isoenzyme, and its enhancement by concurrent inhibition of the guanosine 3':5'-cyclic monophosphate (cyclic GMP)-inhibited (PDE3) isoenzyme, on tissue cyclic AMP levels, spasmogen-stimulated phosphoinositide hydrolysis and contractile responses in bovine tracheal smooth muscle (BTSM). In particular, we have concentrated upon the ability of combined PDE3/4 inhibition to aect Ins(1,4,5)P 3 generation and tissue responses to mACh receptor activation.
Methods

Incubation methods
Bovine trachealis muscle was obtained and prepared as described previously (Chilvers et al., 1989a) . Tissue was maintained at 48C in a modi®ed Krebs-Henseleit buer (KHB; composition in mM: NaCl 118, KCl 4.7, NaHCO 3 25, CaCl 2 1.3, K 2 HPO 4 1.2, MgSO 4 1.2, HEPES 5, glucose 10; equilibrated with O 2 /CO 2 (19:1 v/v) and adjusted to pH 7.4) during transportation to the laboratory and dissection to remove the epithelium and connective tissue. For contractile studies, BTSM was cut into strips (approx. 262610 mm) and mounted for tension recording as described previously (Ellis et al., 1995) . For second messenger experiments, the bovine tracheal smooth muscle (BTSM) was cross-chopped (3006300 mm) with a McIlwain tissue-chopper, and slices incubated with multiple changes of KHB (100 ml) at 378C for 45 ± 60 min. Where indicated slices were labelled with myo-[ 3 H]-inositol (1 mCi ml 71 ) for 24 h as described previously (Chilvers et al., 1994) .
Contractile studies
BTSM strips were mounted in 30 ml organ baths containing KHB equilibrated with O 2 /CO 2 at 378C under a resting tension of 0.5 g. After a 60 min stabilization period, during which time the tissue was washed with multiple KHB changes and tension adjusted back to 0.5 g, anti-spasmogenic experiments were performed as described previously (Ellis et al., 1995) to investigate the ability of pretreatment (for 30 min) with PDE3 and/or 4 inhibitors to aect the contraction elicited by either carbachol (0.001 ± 3 mM) or histamine (1 ± 300 mM).
To study phasic contraction studies were performed as above, except that single concentrations of spasmogen were studied, and 10 min before spasmogen addition BTSM strips were exposed to Ca 2+ -free KHB containing 2 mM EGTA (Tagliente et al., 1992) . Under these conditions a rapid phasic contraction to spasmogen was observed. Within 30 s the tension declined to resting levels and the tissue was extensively washed with normal KHB and allowed to re-stabilize for 30 min before further manipulation.
Spasmogen-stimulated total [ 3 H]-inositol phosphate accumulation
After the 24 h labelling period BTSM slices were washed back into KHB and 75 ml packed BTSM slices transferred to 400 ml KHB containing 1 mCi ml 71 myo-[ 3 H]-inositol and 5 mM LiCl (®nal concentrations). Drug additions were made as indicated in the Results section and incubations terminated by addition of 500 ml ice-cold 10% perchloric acid and immediate transfer of samples to an icebath. After 30 min samples were centrifuged (40006g, 15 min, 48C) and the supernatant neutralized with 1,1,2-trichlorotri¯uoroethane/tri-n-octylamine (Chilvers et al., 1994) (Challiss et al., 1992) .
Spasmogen-stimulated changes in Ins(1,4,5)P 3 and eects of PDE inhibition on cyclic AMP levels
The eects of isoenzyme-selective PDE inhibitors or vehicle on cyclic AMP and Ins(1,4,5)P 3 mass levels in BTSM slices were assessed in the absence or presence of a subsequent spasmogen challenge. Incubations were terminated as described above for [ 3 H]-InsP X recovery. Cyclic AMP levels were quanti®ed in neutral tissue extracts by the method of Brown et al. (1971) . Ins(1,4,5)P 3 levels were quanti®ed by the method of Challiss et al. (1988) . 
Data analysis
Results
Eects of isoenzyme-selective PDE inhibitors on cyclic AMP accumulation
A number of PDE3-and PDE4-selective PDE inhibitors were assessed for their ability to increase basal cyclic AMP accumulation in BTSM slices. Neither PDE3-selective (siguazodan, cilostamide, ORG 9935), nor PDE4-selective (Ro 20-1724, denbufylline, rolipram) inhibitors used at isoenzymespeci®c concentrations (Torphy & Cieslinski, 1990; Qian et al., 1993; Beavo, 1995) produced a signi®cant elevation in cyclic AMP concentration during a 30 min exposure time (data not shown). However, in the presence of PDE3 inhibition a PDE4 inhibitor could signi®cantly and concentration-dependently increase cyclic AMP accumulation. For example, in the presence of 1 mM ORG 9935, rolipram caused a concentration-dependent (7log EC 50 (M), 6.55+0.15; n=3) increase in cyclic AMP accumulation which amounted to a 6 fold-over-basal increase at 100 mM rolipram and which was about 70% of the response to a maximally-eective concentration of isoprenaline (Figure 1 ).
Comparison of the eects of rolipram on spasmogenstimulated phosphoinositide turnover in the absence and presence of PDE3 inhibition
Previous studies have demonstrated that rolipram inhibits both inositol phospholipid hydrolysis (Hall et al., 1989b) and contractile responses (Hall & Hill, 1988; Madison & Brown, 1988; Oer et al., 1991) . Thus a small rightward-shift in the concentration-eect curve for carbachol-stimulated BTSM slices were prepared as described in the Methods section. Slices were incubated in the absence or presence of ORG 9935 (1 mM) and the indicated concentration of rolipram for 30 min. For comparison, the eect of a maximally-eective concentration of isoprenaline (+I; 10 mM for 10 min) was also assessed. Incubations were terminated and cyclic AMP concentration determined as described in the Methods section. Neither ORG 9935 (1 mM), nor rolipram (100 mM) alone signi®cantly aected basal cyclic AMP levels (C). Data are shown as means with vertical lines indicating s.e.mean for at least 4 separate experiments performed in duplicate or triplicate. concentrations of the spasmogen (Figure 3a) . At 1 mM carbachol, rolipram (100 mM), and rolipram (100 mM)+ORG 9935 (1 mM), caused 44 and 82% decreases in the [ 3 H]-InsP X response, respectively, although only the latter eect attained statistical signi®cance (Figure 3b ). Despite the modest size of the inhibitory eect of rolipram in the presence of the PDE3 inhibitor, the eect appeared to be concentration-dependent and evident at very low concentrations of the PDE4-selective inhibitor (1 ± 10 nM; Figure 4 ).
Eect of rolipram on spasmogen-stimulated contraction in the absence and presence of PDE3 inhibition under normal and Ca 2+ -free conditions
Concentration-eect curves to carbachol and histamine were constructed by incremental addition of either spasmogen to BTSM strips. In general, full spasmogen-stimulated concentration-eect curves were constructed before exposure to PDE inhibitor(s) and then the incremental protocol repeated in the presence of ORG 9935 and/or rolipram, or vehicle (to act as a time-matched control). Figure 5a shows data for the eects of PDE3/4 inhibition at single concentrations of carbachol (1 mM) or histamine (30 mM). ORG 9935 (1 mM) had no eect on either carbachol-or histamine-stimulated contraction. Rolipram was without eect on the carbachol-mediated contractile response, but had a signi®cant inhibitory eect on the response to histamine. However, the presence of both PDE inhibitors caused essentially 100% inhibition (N.B. resting tension 0.5 g) of the histamine-evoked contraction, and a signi®cant 44% inhibition of that evoked by carbachol (Figure 5a ). In the absence of extracellular Ca 2+ (Ca 2+ e ) both carbachol (1 mM) and histamine (30 mM) caused transient, phasic contractions of BTSM strips. Pretreatment with rolipram (100 mM), or ORG 9935 (1 mM) had no signi®cant eect on the subsequent phasic contraction elicited by either spasmogen (Figure 5b ). However, co-addition of rolipram+ORG 9935 signi®cantly attenuated the contractions elicited by carbachol and histamine by 40% and 490%, respectively ( Figure 5b ). As the phasic contraction of airways smooth muscle is considered to involve the generation of Ins(1,4,5)P 3 and mobilization of intracellular Ca 2+ -stores (Hashimoto et al., 1985; MillerHance et al., 1988; Chilvers et al,. 1989b) , we investigated whether the attenuation of this response by combined PDE inhibition might involve an action at the level of Ins(1,4,5)P 3 mass generation.
Inhibitory eects of combined PDE3/PDE4 inhibition on spasmogen-stimulated Ins(1,4,5)P 3 mass generation As previously shown (Chilvers et al., 1989b; , carbachol (100 mM) caused a rapid, transient increase in Ins(1,4,5)P 3 mass which was maximal within 5 s and had returned to basal levels by 60 s (Figure 6 ). In contrast to the extremely transient nature of the second messenger response, it is known that total [ 3 H]-InsP X accumulation continues at an apparently constant rate for 430 min . Pretreatment with rolipram (100 mM), or ORG 9935 (1 mM) had no signi®cant eect on the basal Ins(1,4,5)P 3 level or the subsequent Ins(1,4,5)P 3 response to carbachol (at 5 s: +CCh, 22.1+1.2; Eects of PDE3/4 inhibition on contractile responses to carbachol and histamine. Contractile responses of BTSM strips were monitored as described in the Methods section. In (a), strips were incubated with ORG 9935 (1 mM), rolipram (10 mM) or a combination of both agents (ORG 9935/rolipram) for 30 min before construction of concentration-eect curves for carbachol or histamine. Only data for the eects seen at 1 mM carbachol and 30 mM histamine are shown. In (b), strips also were incubated with ORG 9935 (1 mM), rolipram (10 mM) or a combination of both agents (ORG 9935/ rolipram) for 30 min. However, for the ®nal 10 min the medium was changed to a Ca 2+ -free KHB containing 2 mM EGTA. Carbachol (1 mM) or histamine (30 mM) was added and the initial peak of the phasic contractions recorded. Data are shown as means+s.e.mean for at least 3 separate BTSM preparations performed in triplicate. Statistically signi®cant dierences from the respective control spasmogen-stimulated contractile response are indicated as *P50.05; **P50.01; ***P50.001. +ORG 9935/CCh, 22.4+1.7; +rolipram/CCh, 20.2+1.6 pmol mg 71 protein; n=4). However, co-addition of rolipram+ORG 9935 signi®cantly attenuated the Ins(1,4,5)P 3 response (Figure 6 ), decreasing the initial response to carbachol by at least 50%.
The eect of PDE3/PDE4 inhibition was evident at all concentrations of carbachol examined (Figure 7a) , and in the presence of ORG 9935 (1 mM), rolipram caused a concentration-dependent inhibition of carbachol-stimulated Ins(1,4,5)P 3 response (7log EC 50 (M), 6.77+0.21; n=4: Figure 7b) No pre-addition ORG 9935/ rolipram Figure 6 Eect of PDE3/4 inhibition on the time-course of carbachol-stimulated Ins(1,4,5)P 3 mass accumulation. BTSM slices were prepared as described in the Methods section. Slices were incubated in the absence or presence of rolipram (100 mM)+ORG 9935 (1 mM) for 30 min, followed by challenge with carbachol (100 mM) for the times indicated. Incubations were terminated and Ins(1,4,5)P 3 concentration determined as described in the Methods section. Data are shown as means with vertical lines indicating s.e.mean for 5 separate experiments performed in triplicate. Statistically signi®cant dierences for +PDE3/4 inhibition at a given time-point are indicated as *P50.05; **P50.01. Figure 7 Characterization of the eects of PDE3/4 inhibition on carbachol-stimulated Ins(1,4,5)P 3 mass accumulation. BTSM slices were prepared as described in the Methods section. In (a), slices were incubated in the absence or presence of rolipram (100 mM)+ORG 9935 (1 mM) for 30 min, followed by challenge with the indicated concentrations of carbachol for 10 s. In (b), slices were incubated with ORG 9935 (1 mM) and the indicated concentration of rolipram for 30 min before addition of carbachol (100 mM) for 10 s. The basal level of Ins(1,4,5)P 3 is also shown (Control). Incubations were terminated and Ins(1,4,5)P 3 concentration determined as described in the Methods section. Data are shown as means with vertical lines indicating s.e.mean for 3 (a) or 4 (b) separate experiments performed in triplicate. Bovine tracheal smooth muscle slices were incubated in the absence or presence of rolipram (100 mM)+ORG 9935 (1 mM) for 30 min before addition of carbachol (CCh; 100 mM) or vehicle for the times indicated. Neutralized tissue extracts were analysed for Ins (1,4,5)P 3 and cyclic AMP content as described in the Methods section. Data are shown as means+s.e.mean for 4 (+Ca ) separate experiments performed in triplicate. Statistical analysis was performed by use of Student's t test (unpaired observations). Statistically signi®cant dierences with respect to the eects of rolipram+ORG 9935 on carbachol-stimulated increases in Ins (1,4,5)P 3 are shown as *P50.05; **P50.01; and for the eect of carbachol addition on cyclic AMP levels as {{P50.01. medium basal and carbachol-stimulated Ins(1,4,5)P 3 levels were slightly lower in BTSM slices, although a rapid and robust 2 ± 3 fold increase in second messenger concentration was observed under both conditions. The presence of PDE3/4 inhibitors exerted a more profound eect on carbacholstimulated Ins(1,4,5)P 3 generation in the absence (82% inhibition) compared to the presence (49% inhibition) of Ca 2+ e (Table 1 ). In addition to monitoring changes in Ins(1,4,5)P 3 , cyclic AMP levels were also assessed. ] e =1.3 mM) carbachol addition caused an immediate and marked (67% at 10 s) decrease in BTSM cyclic AMP levels in the presence of PDE3/4 inhibition, when Ca 2+ was removed from the medium carbachol addition failed to decrease cyclic AMP concentration (Table 1 ). Thus, it is possible that the eectiveness of PDE3/4 inhibition to attenuate carbacholstimulated Ins(1,4,5)P 3 accumulation may depend on whether carbachol addition per se can exert an action (dependent upon [Ca 2+ ] e ) to decrease BTSM cyclic AMP concentration.
Discussion
Previous studies by a number of groups have catalogued the expression of multiple isoenzymes of cyclic nucleotide PDE in airways smooth muscle from various species, including dog (Torphy & Cieslinski, 1990) , cow (Giembycz & Barnes, 1991; Shahid et al., 1991) and man (de Boer et al., 1992; Rabe et al., 1993; Torphy et al., 1993) . In addition, functional consequences of isoenzyme-selective PDE inhibition on inherent and spasmogen-stimulated tone have been investigated in airways smooth muscle preparations. Although the relative importance of PDE3 and PDE4 in regulating cyclic AMP levels varies between species (Tomkinson et al., 1993) , it is clear from studies in bovine and human airways that combined inhibition of PDE3/4 is more eective in relaxing inherent (Rabe et al., 1993) or spasmogen-induced tone de Boer et al., 1992; Torphy et al., 1993) than inhibition of either isoenzyme alone. Similar synergistic PDE3/4 interactions have also been observed in vascular smooth muscle (Eckly & Lugnier, 1994; Pan et al., 1994) .
In the present study we have used isoenzyme-selective inhibitors to investigate the eects of types 3 and 4 PDE inhibition on cyclic AMP levels and phosphoinositide responses, in conjunction with functional assessment in BTSM. In agreement with previous functional studies, and the limited information available regarding second messenger regulation by PDE inhibitors (Hall et al., 1989a,b; Oer et al., 1991) , we have shown that combined PDE3 and PDE4 inhibition has greater-than-additive eects upon all responses measured. Thus, whilst either PDE3 or PDE4 inhibition alone did not signi®cantly eect cyclic AMP levels in BTSM, combined PDE3/4 inhibition resulted in a marked increase in this second messenger. Similarly, although the PDE4-selective inhibitor rolipram at high concentrations caused a similar maximal inhibition of histamine-stimulated [ Despite the modest eects of PDE inhibition (or any cyclic AMP-elevating manipulation) on mACh receptor-mediated responses in BTSM, we have demonstrated for the ®rst time that the carbachol-stimulated Ins(1,4,5)P 3 mass response can be signi®cantly aected by combined PDE3/4 inhibition, whilst selective inhibition of either PDE3 or PDE4 was without eect. The initial spasmogen-evoked increase in Ins(1,4,5)P 3 was attenuated by 50% in the absence of maximally-eective concentrations of rolipram and ORG 9935, and this correlated with a similar marked eect of combined PDE3/4 inhibition on carbachol-stimulated phasic contraction in BTSM strips. Furthermore, if the conditions under which the functional eects were examined were more closely adhered to in the second messenger studies (i.e. in the absence of Ca 2+ e ) a greater (480%) inhibitory eect on spasmogen-stimulated Ins(1,4,5)P 3 accumulation could be observed. Thus, in contrast to previous (and present) -channel antagonists, occurs via a common mechanism (Challiss et al., 1992; (Chilvers et al., 1994) . Furthermore, it should be noted that time-course studies have shown that inhibition of [ 3 H]-InsP X accumulation only becomes evident 2 ± 10 min after histamine challenge, even if BTSM is preincubated (for 430 min) with agents which elevate cyclic AMP levels or exert other inhibitory eects (Hall & Hill, 1988; Challiss et al., 1992) . This suggests that whilst agents which limit Ca 2+ -entry can inhibit sustained agonist-stimulated [ 3 H]-InsP X accumulation, the relevance of this to the modulation of functional smooth muscle responses remains unclear. We have shown previously that whilst agonist-stimulated [ 3 H]-InsP X accumulation (in the presence of Li + ) and inositol phospholipid hydrolysis are sustained for long periods (530 min), the agonist-stimulated increase in Ins(1,4,5)P 3 occurs only transiently and returns to basal or sub-basal levels within 30 ± 60 s of agonist addition (Chilvers et al., 1989b; -entry during the sustained phase of phosphoinositide hydrolysis, such a mechanism cannot explain the more dramatic eect on Ins(1,4,5)P 3 generation.
At present it is unclear how PDE3/4 inhibition results in an attenuation of Ins(1,4,5)P 3 generation stimulated by mACh receptor activation. An inhibitory eect of cyclic AMPelevating agents on muscarinic receptor-stimulated Ca 2+ mobilization has been demonstrated in bovine and canine airways smooth muscle (Takuwa et al., 1988; Ozaki et al., 1990; Hoiting et al., 1996) . However, this eect has been considered to occur independently of changes in muscarinic receptor-stimulated Ins(1,4,5)P 3 generation, as this process has been assumed, until now, to be insensitive to modulation by cyclic AMP. The present data strongly suggests that modulation of Ins(1,4,5)P 3 concentration may also contribute to the attenuation of spasmogen-stimulated Ca 2+ -mobilization. It is interesting to note that changes in both Ins(1,4,5)P 3 and cyclic AMP levels occur when BTSM is challenged with carbachol in the presence of ORG 9935 and rolipram. Thus, whilst PDE3/4 inhibition attenuates carbachol-stimulated Ins(1,4,5)P 3 generation, mACh receptor activation also appears simultaneously to aect tissue cyclic AMP levels, causing a rapid and transient decrease. It is possible that the reduction in cyclic AMP concentration results from activation of M 2 -mACh receptor leading to inhibition of adenylyl cyclase activity (Challiss et al., 1993) . However, the inhibitory eect of carbachol appears to require the presence of Ca 2+ e as no signi®cant decrease in cyclic AMP levels was observed when BTSM was exposed to carbachol in nominally Ca 2+ -free medium. Furthermore, the lack of a suppressant eect of carbachol on cyclic AMP levels coincides with a greater inhibitory eect of PDE3/4 inhibition on spasmogenstimulated Ins(1,4,5)P 3 generation. One possible explanation for these observations is that increases in cyclic AMP caused by selective inhibition of PDE3/4 can profoundly inhibit carbachol-stimulated Ins(1,4,5)P 3 , but this eect is fully observed only under Ca 2+ -free conditions. Thus, in the presence of Ca 2+ e mACh receptor activation causes a decrease in cyclic AMP levels and this reduces the extent of the inhibitory eect on agonist-stimulated Ins(1,4,5)P 3 generation.
The Ca 2+ -dependent modulation of cyclic AMP by mACh receptors could result from eects on cyclic AMP synthesis by adenylyl cyclase or degradation, for example by Ca 2+ -stimulated PDE .
In conclusion, the present study has demonstrated that the pathway by which muscarinic receptor activation can generate Ins(1,4,5)P 3 , leading to Ca 2+ -mobilization and airways smooth muscle contraction, can be inhibited by combined isoenzymeselective inhibition of PDE3 and 4 activities, but not separate inhibition of either activity alone. Thus, in contrast to a recent study in mesangial cells where PDE3 and 4 activities were shown to modulate distinct signalling pathways through compartmentation of PDE activities to cellular cyclic AMP microenvironments (Chini et al., 1997) , inhibition of PDE3 and 4 activities can modulate a common cyclic AMP pool in airways smooth muscle. Although the precise locus at which cyclic AMP modulates the initial rate of phosphoinositide hydrolysis has not been de®ned, the present data suggest that selective PDE inhibition can modify the contractile response in airways smooth muscle via eects on Ins(1,4,5)P 3 generation.
